Fig 1.
Flow diagram for search and selection of articles.
Table 1.
Eligible Study Characteristics.
Table 2.
Quality Review Scores.
Table 3.
Evidence of MAYV infection in non-human primates.
Table 4.
Evidence of MAYV infection in birds.
Table 5.
Evidence of MAYV infection in mammals (excluding non-human primates).
Fig 2.
Georeferenced locations of MAYV positivity in non-human animals and arthropods.
The finest spatial scale is presented where possible. One MAYV isolate detected in a migrating bird in Louisiana is not included in the map. The base map layer was generated using the geoBoundaries Comprehensive Global Administrative Zones (CGAZ) dataset available at https://www.geoboundaries.org/downloadCGAZ.html.
Table 6.
Domestic and sentinel animals with evidence of MAYV infection.
Fig 3.
Forest plot of non-human primates from meta-analysis of pooled MAYV seroprevalence.
Estimates are based on random effects model with Freeman-Tukey double arcsine transformation. All samples that tested MAYV-positive are included, regardless of test method.
Fig 4.
Forest plots of mammal orders (excluding primates) from meta-analysis of pooled MAYV seroprevalence.
Estimates are based on random effects model with Freeman-Tukey double arcsine transformation. All samples that tested MAYV-positive are included, regardless of test method.
Fig 5.
Forest plots of avian orders from meta-analysis of pooled MAYV seroprevalence.
Estimates are based on random effects model with Freeman-Tukey double arcsine transformation. All samples that tested MAYV-positive are included, regardless of test method.
Table 7.
Pooled Seroprevalence Table (Random effects with Freeman-Tukey double arcsine transformation).
Table 8.
Evidence of MAYV infection in arthropods.